益生股份(002458) - 2024 Q1 - 季度财报

Financial Performance - The company's total revenue for Q1 2024 was ¥687,415,520.68, representing a decrease of 24.75% compared to ¥913,509,081.99 in the same period last year[16]. - Net profit attributable to shareholders for Q1 2024 was ¥109,337,521.77, down 65.16% from ¥313,826,804.93 year-on-year[16]. - Basic earnings per share for Q1 2024 were ¥0.1, down 68.75% from ¥0.32 in the same period last year[16]. - Total profit decreased by 66.65% to $109,789,387.78 primarily due to lower prices for main products[26]. - Net profit fell by 66.61% to $109,861,623.52, attributed to lower prices for parent and commercial chicken breeds[26]. - Total comprehensive income for the current period is 109,861,623.52 CNY, compared to 329,022,286.93 CNY in the previous period, a decrease of approximately 66.66%[43]. - The net profit for the current period is 109,861,623.52 CNY, a decrease from 329,022,286.93 CNY in the previous period, representing a decline of approximately 66.66%[42]. Cash Flow and Liquidity - The net cash flow from operating activities decreased by 57.05%, amounting to ¥161,598,386.36 compared to ¥376,239,377.51 in the previous year[16]. - Cash flow from operating activities netted 161,598,386.36 CNY, down from 376,239,377.51 CNY, a decline of about 57.00%[44]. - Cash outflow from operating activities totaled 553,063,944.33 CNY, slightly down from 564,701,262.60 CNY, a decrease of about 2.83%[44]. - The cash and cash equivalents at the end of the period amounted to 783,620,771.63 CNY, down from 382,409,192.88 CNY, indicating a decrease of approximately 105.00%[44]. Assets and Liabilities - Total assets at the end of Q1 2024 were ¥6,561,604,512.37, a slight decrease of 0.20% from ¥6,574,994,691.06 at the end of the previous year[16]. - The company reported a total liability of ¥2,197,960,960.91 as of the end of the first quarter of 2024, an increase from ¥2,036,653,687.12 in the previous period[36]. - The equity attributable to shareholders decreased by 2.75% to ¥4,299,697,048.28 from ¥4,421,287,307.41 at the end of the previous year[16]. - The total equity attributable to shareholders was ¥4,299,697,048.28, down from ¥4,421,287,307.41 year-over-year[36]. Operational Metrics - The company's inventory increased to ¥440,208,321.42, up from ¥415,355,197.48 at the beginning of the period[5]. - Short-term borrowings rose to ¥800,827,471.24, an increase from ¥673,723,922.06 at the beginning of the period[5]. - The total operating costs for the first quarter of 2024 were ¥557,993,851.56, down from ¥578,255,565.73 year-over-year[36]. - Operating profit decreased significantly to 110,480,450.27 CNY from 329,065,059.31 CNY, indicating a drop of approximately 66.48%[42]. Shareholder Information - The number of common shareholders at the end of the reporting period was 52,765[27]. - The largest shareholder, Cao Jisheng, holds 40.82% of the shares, totaling 451,599,044 shares[27]. - The company has a total of 1,106,412,915 shares outstanding, with no changes reported in the share capital[36]. Government and Financial Support - The company reported a government subsidy of ¥863,135.79 during the quarter, contributing positively to the financial results[22]. - Financial expenses dropped by 58.70% to $8,911,407.03 due to reduced loan interest expenses and increased interest income[26]. - The company incurred financial expenses of 8,911,407.03 CNY, a significant decrease from 21,576,137.67 CNY, reflecting a reduction of approximately 58.76%[42]. Research and Development - Research and development expenses increased to 26,386,279.18 CNY from 22,134,558.05 CNY, reflecting a growth of about 19.88%[42]. Market Strategy - The company is focusing on expanding its market presence and developing new products, although specific details were not provided in the report[36]. - The company has not disclosed any new mergers or acquisitions during this reporting period[36]. Audit and Reliability - The report indicates that the first quarter results have not been audited, which may affect the reliability of the figures presented[38].